Committee Chairman Sen. Chuck Grassley, R-Iowa, and ranking member Sen. Ron Wyden, D-Ore., invited the following companies to attend:
- AbbVie
- AstraZeneca
- Bristol-Myers Squibb Co.
- Johnson & Johnson
- Merck & Co.
- Pfizer
- Sanofi
The Senate Finance Committee held an initial hearing on drug prices in January, during which Mr. Grassley denounced drug executives’ lack of attendance. The senators said some of these drug companies have been re-invited to the next hearing, although they did not say which.
More articles on pharmacy:
Despite controversies, J&J ranks among Fortune’s most-admired companies
Bristol-Myers swings to $1.2B profit in Q4
Bernie Sanders takes aim at drug’s $375K price tag
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
